Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997347 · ClinicalTrials.gov registry record · Phase 4
The Extended Gestational Age Medical Abortion Study
A Phase 4 study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,400
- Enrollment target
NCT00997347: Completed Phase 4 study, sponsored by Gynuity Health Projects.
NCT00997347 is a Phase 4 study that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,400 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (170% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00997347, a Phase 4 study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.
Interventions
- DRUG Mifepristone and misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
What the finished NCT00997347 record still lists
NCT00997347 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (170% higher).
The record links to 0 conditions, and to 1 intervention - of which Mifepristone and misoprostol is the first listed.
NCT00997347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00997347 about?
NCT00997347 is a clinical study titled "The Extended Gestational Age Medical Abortion Study". This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 d...
What is the current status of trial NCT00997347?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,400 participants. The study started on 2009-07. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00997347?
The interventions under investigation include: Mifepristone and misoprostol (DRUG).
Who is sponsoring clinical trial NCT00997347?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00997347's enrollment target sits among peer trials
1,400 55th of 2000 higher than 1,946 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia